All data (n = 502 individuals)a | Cohort extended dataset (n = 205) | |
---|---|---|
Gender | ||
Female | 252 | 100 |
Male | 237 | 95 |
Unknown | 13 | 10 |
Age | ||
At infection one (mean years ± SD) | 7.6 ± 3.0 | 9.0 ± 1.7 |
At infection two (mean years ± SD) | 11.2 ± 3.0 | 11.2 ± 2.0 |
Serologic response at infection one b | ||
Primary | 84 | 6 |
Secondary | 263 | 59 |
Unknown (symptomatic) | 15 | - |
Unknown (Subclinical/nonhospitalized) | 56 | 56 |
Unknown (Subclinical) | 84 | 84 |
Clinical category at infection one c | ||
Symp. (DHF) | 201 | 24 |
Symp. (DHF/hospitalized DF) | 16 | 3 |
Symp. (hospitalized DF) | 123 | 16 |
Symp. (non-hospitalized DF) | 19 | 19 |
Symp. (hospitalized/non-hospitalized DF) | 3 | 3 |
Subclinical/non-hospitalized | 56 | 56 |
Subclinical | 84 | 84 |
Clinical category at infection two c | ||
Symp. (DHF) | 201 | 17 |
Symp. (DHF/hospitalized DF) | 13 | - |
Symp. (hospitalized DF) | 112 | 16 |
Symp. (non-hospitalized DF) | 33 | 29 |
Symp. (hospitalized/non-hospitalized DF) | 1 | 1 |
Subclinical/non-hospitalized | 42 | 42 |
Subclinical | 100 | 100 |